Forster Eliot bought PLX
September 3, 2025 · Form 4 insider transaction
Forster Eliot bought 7,500 shares of Protalix BioTherapeutics, Inc., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
7,500
Price
N/A
Total value
N/A
InsiderForster Eliot
RoleDirector
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateSeptember 3, 2025
Filing dateSeptember 4, 2025
Shares owned after7,500
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
Represents restricted shares of common stock awarded to the Reporting Person under the Amended and Restated Protalix BioTherapeutics, Inc. 2006 Stock Incentive Plan, as amended (the "Plan"). The restricted shares vest in 12 equal quarterly installments commencing upon the date of grant.